Fibrocell Science (FCSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Sales | 79 | 0 | 49 | 0 | 20 |
| Cost of Goods | 48 | 1 | N/A | N/A | N/A |
| Gross Profit | 32 | -1 | -433 | N/A | 20 |
| Operating Expenses | 2,524 | 2,253 | 2,345 | 1,498 | 1,248 |
| Operating Income | -2,445 | -2,252 | -2,297 | -1,498 | -1,228 |
| Other Income | 3 | 63 | 158 | 32 | 47 |
| Pre-tax Income | -2,441 | -2,189 | -2,139 | -1,467 | -1,181 |
| Net Income Continuous | -2,441 | -2,189 | -2,139 | -1,467 | -1,181 |
| Net Income | $-2,441 | $-2,189 | $-2,139 | $-1,467 | $-1,181 |
| EPS Basic Total Ops | -60.01 | -56.26 | -307.53 | -45.00 | -30.00 |
| EPS Basic Continuous Ops | -59.67 | -53.46 | -52.67 | -36.21 | -29.16 |
| EPS Diluted Total Ops | -60.01 | -56.26 | -307.53 | -45.00 | -30.00 |
| EPS Diluted Continuous Ops | -59.67 | -53.46 | -52.67 | -36.21 | -29.16 |
| EBITDA(a) | $-2,231 | $-2,109 | $-2,220 | $-1,485 | $-1,223 |